XML 45 R19.htm IDEA: XBRL DOCUMENT v3.25.4
Stockholders' Equity
 12 Months Ended
Dec. 31, 2025
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Stockholders’ EquityPreferred Stock
The Company has the authority to issue 10,000,000 shares of preferred stock with a par value of $0.001 per share.  The Board of
Directors (the “Board”) has the authority, without action by the Company’s stockholders, to designate and issue shares of preferred stock in
one or more series.  The Board is also authorized to designate the rights, preferences, and voting powers of each series of preferred stock,
any or all of which may be greater than the rights of the common stock including restrictions of dividends on the common stock, dilution of the
voting power of the common stock, reduction of the liquidation rights of the common stock, and delaying or preventing a change in control of
the Company without further action by the Company’s stockholders.  To date, the Board has not designated any rights, preferences, or
powers of any preferred stock, and as of December 31, 2025 and 2024, no shares of preferred stock were issued or outstanding.
Common Stock
The Company has the authority to issue 200,000,000 shares of common stock with a par value of $0.001 per share.  Subject to the
preferred rights of the holders of shares of any class or series of preferred stock as provided by the Board with respect to any such class or
series of preferred stock, the holders of the common stock shall be entitled to receive dividends, as and when declared by the Board.  In the
event of any liquidation, dissolution, or winding up of the Company, whether voluntary or involuntary, after the distribution or payment to the
holders of shares of any class or series of preferred stock as provided by the Board with respect to any such class or series of preferred
stock, the remaining assets of the Company available for distribution to stockholders shall be distributed among and paid to the holders of
common stock ratably in proportion to the number of shares of common stock held by them.
Share Repurchase ProgramsThe Company’s Board, from time-to-time, has authorized share repurchase programs under which the Company may, at the
discretion of management, repurchase its outstanding common stock in the open market, or in privately negotiated transactions, in
compliance with applicable state and federal securities laws.  The timing and amounts of any purchase under the Company’s share
repurchase programs is based on market conditions and other factors including price, regulatory requirements, and capital availability.  The
Company accounts for stock repurchases under these programs using the cost method.  As of December 31, 2025, the Company has
repurchased 13,967,259 shares of its common stock at an aggregate cost of $166.1 million under all share repurchase programs.
November 2024 Authorization
On November 18, 2024, the Company announced that the Board authorized a share repurchase program under which the Company
may repurchase its outstanding common stock, at the discretion of management, up to $50.0 million in aggregate cost, which included both
the share value of the acquired common stock and the fees charged in connection with acquiring the common stock (the “November 2024
Authorization”).  On December 11, 2024, the Company concluded all share repurchases under the November 2024 Authorization. Under the
November 2024 Authorization, the Company repurchased 3,248,533 shares at an aggregate cost of $50.0 million.
February 2025 Authorization
On February 26, 2025, the Company announced that the Board authorized a share repurchase program under which the Company
may repurchase its outstanding common stock, at the discretion of management, for up to $30.0 million in aggregate cost, which includes
both the share value of the acquired common stock and the fees charged in connection with acquiring the common stock (the “February 2025
Authorization”). The February 2025 Authorization will expire in February 2026.
The following table presents the share repurchase activities under the February 2025 Authorization as of December 31, 2025.
Number of Shares
Purchased
Average Price Paid
per Share(1)
Plan Activity
(In millions)
February 2025 Authorization
$30.0
Repurchases under February 2025 Authorization
2,183,648
$13.72
(30.0)
Remaining amount under February 2025 Authorization
$—
(1)Excluding commissions
The Company completed all purchases under the February 2025 Authorization in August 2025.
August 2025 Authorization
On August 6, 2025, the Board announced a share repurchase program under which the Company may repurchase its outstanding
common stock, at the discretion of management, for up to $25.0 million in aggregate cost, which includes both the share value of the
acquired common stock and the fees charged in connection with acquiring the common stock (the “August 2025 Authorization”). The August
2025 Authorization will expire in May 2026. The Company began to purchase under the August 2025 Authorization in August 2025.
The following table presents the share repurchase activities under the August 2025 Authorization as of December 31, 2025.
Number of Shares
Purchased
Average Price Paid
per Share(1)
Plan Activity
(In millions)
August 2025 Authorization
25.0
Repurchases under August 2025 Authorization
386,566
$14.52
(5.6)
Remaining amount under August 2025 Authorization
$19.4
(1)Excluding commissions